Gilead Sciences has agreed to purchase the remainder of improvement accomplice Arcellx in a deal that values the biotechnology firm at about $7.8 billion at closing.
Source link
Gilead Sciences to Buy Arcellx in Deal Valued at $7.8 Billion
Related Posts
The market powered through a tough earnings week, we’re not ‘out of the woods yet’
CNBC’s Jim Cramer mentioned the market simply powered by the hardest week of earnings “with flying colours,” however warned that…
6 Best Phones You Can’t Buy in the US (2025), Tested and Reviewed
Other Good International Phones These phones are worth considering if you have yet to see something you like. Xiaomi Poco…
Meta commits to spending additional $21 billion with CoreWeave
Arda Kucukkaya | Anadolu | Getty Photographs Meta has dedicated to spending an extra $21 billion on AI cloud infrastructure…